Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $484.7100 (-0.81%) ($484.7100 - $484.7100) on Tue. May. 4, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.51% (three month average) | RSI | 54 | Latest Price | $484.7100(-0.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.3% a day on average for past five trading days. | Weekly Trend | REGN declines -1.1% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) XLV(42%) DIA(36%) SPLV(36%) IWD(35%) | Factors Impacting REGN price | REGN will decline at least -0.755% in a week (0% probabilities). VIXM(-20%) TBT(-7%) UUP(-6%) VXX(-5%) USO(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.755% (StdDev 1.51%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $489.08 | 5 Day Moving Average | $485.94(-0.25%) | 10 Day Moving Average | $490.42(-1.16%) | 20 Day Moving Average | $489.08(-0.89%) | To recent high | -4.2% | To recent low | 8.5% | Market Cap | $51.393b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |